Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma

Journal of Clinical Oncology

Volumn 4, Issue 7, 1986, Pages 1068-1073

  Wils, J ^a   Blijham, G ^a   Naus, A ^a   Belder, C ^b   Boschma, F ^b   Bron, H ^b   Ceelen, T ^b   Eekhout, A ^b   von Erp, J ^b   Geelen, P ^b  

^a LAURENTIUS HOSPITAL   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADVERSE DRUG REACTION; ALOPECIA; ANEMIA; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CARDIOMYOPATHY; CARDIOTOXICITY; DRUG EFFICACY; DRUG THERAPY; ENDOCRINE SYSTEM; FEMALE GENITAL SYSTEM; GASTROINTESTINAL TOXICITY; HEART; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; MAJOR CLINICAL STUDY; NAUSEA; NEPHROTOXICITY; OVARY CARCINOMA; PRIORITY JOURNAL; SKIN TOXICITY; SURGERY; SURVIVAL; THERAPY; VOMITING;

EID: 0022526981     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1986.4.7.1068     Document Type: Article

References (0)